U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06993038) titled 'Adenosine vs Diltiazem for Treatment of SVT in the ED' on April 03.
Brief Summary: This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Supraventricular Tachycardia (SVT)
Intervention:
DRUG: adenosine
IV adenosine at standard doses for SVT (6 mg, 12 mg)
DRUG: diltiazem
IV diltiazem at standard doses for SVT (0.25 mg/kg)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Anne E. Zepeski
Information provided by (Respo...